These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 17164563)

  • 21. Revascularization use and survival outcomes after cardiac catheterization in British Columbia and Alberta.
    Thompson CR; Humphries KH; Gao M; Galbraith PD; Norris C; Carere RG; Knudtson ML; Ghali WA;
    Can J Cardiol; 2004 Dec; 20(14):1417-23. PubMed ID: 15614334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of psychosocial aspects of motor neurone disease.
    McLeod JE; Clarke DM
    J Neurol Sci; 2007 Jul; 258(1-2):4-10. PubMed ID: 17445834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiology of anxiety disorders in the Australian general population: findings of the 2007 Australian National Survey of Mental Health and Wellbeing.
    McEvoy PM; Grove R; Slade T
    Aust N Z J Psychiatry; 2011 Nov; 45(11):957-67. PubMed ID: 22044173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of amyotrophic lateral sclerosis.
    Kurtzke JF
    Adv Neurol; 1982; 36():281-302. PubMed ID: 6983824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Secular trends in the epidemiology of shingles in Alberta.
    Russell ML; Schopflocher DP; Svenson L; Virani SN
    Epidemiol Infect; 2007 Aug; 135(6):908-13. PubMed ID: 17291380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinically undetected motor neuron disease in pathologically proven frontotemporal lobar degeneration with motor neuron disease.
    Josephs KA; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Dickson DW
    Arch Neurol; 2006 Apr; 63(4):506-12. PubMed ID: 16606762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of incidence to increasing prevalence of multiple sclerosis in Alberta, Canada.
    Warren SA; Svenson LW; Warren KG
    Mult Scler; 2008 Aug; 14(7):872-9. PubMed ID: 18573834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase in motor neuron disease mortality in Spain: temporal and geographical analysis (1990-2005).
    Alonso V; Villaverde-Hueso A; Hens MJ; Morales-Piga A; Abaitua I; de la Paz MP
    Amyotroph Lateral Scler; 2011 May; 12(3):192-8. PubMed ID: 21198417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Help-seeking for substance use, anxiety and affective disorders among young people: results from the 2007 Australian National Survey of Mental Health and Wellbeing.
    Reavley NJ; Cvetkovski S; Jorm AF; Lubman DI
    Aust N Z J Psychiatry; 2010 Aug; 44(8):729-35. PubMed ID: 20636194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increasing incidence and prevalence with limited survival gains among rural Albertans with diabetes: a retrospective cohort study, 1995-2006.
    Johnson JA; Balko SU; Hugel G; Low C; Svenson LW
    Diabet Med; 2009 Oct; 26(10):989-95. PubMed ID: 19900230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and epidemiological features of motor neuron disease in south-western Greece.
    Argyriou AA; Polychronopoulos P; Papapetropoulos S; Ellul J; Andriopoulos I; Katsoulas G; Salakou S; Chroni E
    Acta Neurol Scand; 2005 Feb; 111(2):108-13. PubMed ID: 15644070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders.
    Walker JR; Ediger JP; Graff LA; Greenfeld JM; Clara I; Lix L; Rawsthorne P; Miller N; Rogala L; McPhail CM; Bernstein CN
    Am J Gastroenterol; 2008 Aug; 103(8):1989-97. PubMed ID: 18796096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in the prevalence and comorbidities of diabetes mellitus in nursing home residents in the United States: 1995-2004.
    Zhang X; Decker FH; Luo H; Geiss LS; Pearson WS; Saaddine JB; Gregg EW; Albright A
    J Am Geriatr Soc; 2010 Apr; 58(4):724-30. PubMed ID: 20398154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An all-Ireland epidemiological study of MND, 2004-2005.
    Donaghy C; O'Toole O; Sheehan C; Kee F; Hardiman O; Patterson V
    Eur J Neurol; 2009 Jan; 16(1):148-53. PubMed ID: 19087159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatic healthcare utilization among adults with serious mental illness who are receiving community psychiatric services.
    Dickerson FB; McNary SW; Brown CH; Kreyenbuhl J; Goldberg RW; Dixon LB
    Med Care; 2003 Apr; 41(4):560-70. PubMed ID: 12665719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Affective, somatoform and anxiety disorders in Germany--initial results of an additional federal survey of "psychiatric disorders"].
    Wittchen HU; Müller N; Pfister H; Winter S; Schmidtkunz B
    Gesundheitswesen; 1999 Dec; 61 Spec No():S216-22. PubMed ID: 10726424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Motor neuron disease mortality rates in New Zealand 1992-2013.
    Cao MC; Chancellor A; Charleston A; Dragunow M; Scotter EL
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):285-293. PubMed ID: 29382218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Affective disorders in older inpatients.
    Wetterling T; Junghanns K
    Int J Geriatr Psychiatry; 2004 May; 19(5):487-92. PubMed ID: 15156551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study.
    Alonso A; Logroscino G; Jick SS; Hernán MA
    Eur J Neurol; 2009 Jun; 16(6):745-51. PubMed ID: 19475756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Communicating the diagnosis of motor neurone disease.
    Johnston M; Earll L; Mitchell E; Morrison V; Wright S
    Palliat Med; 1996 Jan; 10(1):23-34. PubMed ID: 8821185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.